Sloan Kettering Study Confirms Connection Between Zantac (ranitidine) and Cancer-Causing NDMA
By Angela Leone
A new study authored by Dr. Lior Z. Braunstein, MD of Memorial Sloan Kettering Cancer Center and published in The Journal of the American Medical Association (JAMA) has confirmed a correlation between acid reflux treatment ranitidine (brand name ZANTAC) and the cancer causing substance N-nitrosodimethylamine, or NDMA. The study created conditions in which ranitidine might […]
Continue reading